Claritev Corporation
CTEVNYSEHealthcare● Active
$26.33
+$0.49(+1.90%)
Market Cap$448868284
P/E Ratio—
52W High$74.07
52W Low$11.5
Claritev Corporation (CTEV) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CTEV · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$4.41
Est. -$3.81 · -15.8%
Revenue
$0.24B
Est. $0.24B · +3.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
CTEV reports quarterly as a NYSE-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.00B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.00B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | -$4.03 | — | — | — | $0.24B | — |
| ▼ Q2 FY2026 | May 7, 2026 | -$3.81 | -$4.41 | -15.8% | $0.24B | $0.24B | +3.5% |
| ▼ Q1 FY2026 | Feb 23, 2026 | $0.85 | -$4.88 | -674.1% | $0.25B | $0.24B | +2.2% |
| ▼ Q4 FY2025 | Nov 7, 2025 | -$3.12 | -$4.07 | -30.4% | $0.25B | $0.24B | +1.9% |
| ▲ Q3 FY2025 | Aug 6, 2025 | -$2.69 | $0.32 | +111.9% | $0.24B | $0.23B | +4.1% |
| ▼ Q2 FY2025 | May 8, 2025 | -$2.20 | -$3.43 | -55.9% | $0.23B | $0.23B | +0.9% |
| ▲ Q1 FY2025 | Feb 25, 2025 | -$9.81 | -$5.14 | +47.6% | $0.23B | $0.23B | -0.9% |
| ▼ Q3 FY2024 | Aug 1, 2024 | -$2.22 | -$35.60 | -1503.0% | $0.23B | $0.25B | -5.0% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
-$4.03
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Miss
EPS Actual
-$4.41
EPS Est.
-$3.81
EPS Surpr.
-15.8%
Revenue
$0.24B
Q1 FY2026
Feb 23, 2026Miss
EPS Actual
-$4.88
EPS Est.
$0.85
EPS Surpr.
-674.1%
Revenue
$0.25B
Q4 FY2025
Nov 7, 2025Miss
EPS Actual
-$4.07
EPS Est.
-$3.12
EPS Surpr.
-30.4%
Revenue
$0.25B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
$0.32
EPS Est.
-$2.69
EPS Surpr.
+111.9%
Revenue
$0.24B
Q2 FY2025
May 8, 2025Miss
EPS Actual
-$3.43
EPS Est.
-$2.20
EPS Surpr.
-55.9%
Revenue
$0.23B
Q1 FY2025
Feb 25, 2025Beat
EPS Actual
-$5.14
EPS Est.
-$9.81
EPS Surpr.
+47.6%
Revenue
$0.23B
Q3 FY2024
Aug 1, 2024Miss
EPS Actual
-$35.60
EPS Est.
-$2.22
EPS Surpr.
-1503.0%
Revenue
$0.23B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-2.94 | $-2.92 | $-2.90 | 1 |
| Q3 FY2027 | $-3.10 | $-3.08 | $-3.06 | 1 |
| Q2 FY2027 | $-3.30 | $-3.28 | $-3.26 | 1 |
| Q1 FY2027 | $-3.40 | $-3.38 | $-3.36 | 1 |
| Q4 FY2026 | $-3.54 | $-3.51 | $-3.49 | 1 |
| Q3 FY2026 | $-3.71 | $-3.68 | $-3.66 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.3B | $0.3B | $0.3B | 1 |
| Q3 FY2027 | $0.3B | $0.3B | $0.3B | 1 |
| Q2 FY2027 | $0.3B | $0.3B | $0.3B | 1 |
| Q1 FY2027 | $0.3B | $0.3B | $0.3B | 1 |
| Q4 FY2026 | $0.3B | $0.3B | $0.3B | 1 |
| Q3 FY2026 | $0.2B | $0.2B | $0.3B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 7, 2026 | -15.8% | $26.47 | $24.21 | -8.54% |
| ▼ Q1 FY2026 | Feb 23, 2026 | -674.1% | $23.27 | $23.23 | -0.17% |
| ▼ Q4 FY2025 | Nov 7, 2025 | -30.4% | $61.96 | $69.25 | +11.77% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +111.9% | $39.52 | $51.14 | +29.40% |
| ▼ Q2 FY2025 | May 8, 2025 | -55.9% | $21.23 | $21.58 | +1.65% |
| ▲ Q1 FY2025 | Feb 25, 2025 | +47.6% | $29.20 | $19.61 | -32.84% |
| ▼ Q3 FY2024 | Aug 1, 2024 | -1503.0% | No price data | $29.20 | — |
Q2 FY2026-8.54%
Report Date
May 7, 2026
EPS Beat/Miss
-15.8%
Price Before
$26.47
Price After
$24.21
Q1 FY2026-0.17%
Report Date
Feb 23, 2026
EPS Beat/Miss
-674.1%
Price Before
$23.27
Price After
$23.23
Q4 FY2025+11.77%
Report Date
Nov 7, 2025
EPS Beat/Miss
-30.4%
Price Before
$61.96
Price After
$69.25
Q3 FY2025+29.40%
Report Date
Aug 6, 2025
EPS Beat/Miss
+111.9%
Price Before
$39.52
Price After
$51.14
Q2 FY2025+1.65%
Report Date
May 8, 2025
EPS Beat/Miss
-55.9%
Price Before
$21.23
Price After
$21.58
Q1 FY2025-32.84%
Report Date
Feb 25, 2025
EPS Beat/Miss
+47.6%
Price Before
$29.20
Price After
$19.61
Q3 FY2024—
Report Date
Aug 1, 2024
EPS Beat/Miss
-1503.0%
Price Before
—
Price After
$29.20
Avg Beat Reaction-1.72%
Avg Miss Reaction+1.18%
Beat Rate2 / 7 quarters
Largest Move-32.84% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CTEV ends December
Claritev Corporation (CTEV) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-4.41 — missing the analyst consensus of $-3.81 by -15.8%. The next CTEV earnings date is expected around September 1, 2026.
Each quarter, investors track CTEV earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CTEV revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CTEV's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CTEV earnings · 5 questionsClaritev Corporation's next earnings report is expected around September 1, 2026. CTEV typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CTEV historically reports after market close (AMC).
CTEV earnings datewhen is CTEV earningsCTEV next earnings datewhen does CTEV report earningsCTEV earnings calendar
▸ Source: FMP · Claritev Corporation SEC filings · US GAAP · Claritev Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026